Metagenomi, Inc. Common Stock
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $123,248,000.
Profit Margin
| 2023 | 44.75M | -68.25M | -152.5% |
|---|
MGX Income Statement (2023 – 2023)
| 2023 | |
|---|---|
Revenue | |
Revenue | 44.75M |
Cost of revenue | 94.40M |
Gross profit | -49.64M |
Operating exp. | |
Research and development | 94.40M |
Selling and marketing | 0 |
Total operating expenses | 123.24M |
Operating income | -78.49M |
Other income (expenses), net | 18.26M |
Income before tax | -60.22M |
Income tax expense | 8.02M |
Net income | -68.25M |
Earnings per share | |
Basic EPS | -1.82 |
Diluted EPS | -1.82 |